Evidence map›Paper›PMID 37015072›Full record

ArticleACS applied materials & interfaces2023

Preservation of Proteins in Human Plasma through Metal-Organic Framework Encapsulation.

Yixuan Wang, Jeremiah J Morrissey, Prashant Gupta, Pradeep Chauhan, Russell K Pachynski, Peter K Harris, Aadel Chaudhuri, Srikanth Singamaneni

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yixuan WangDepartment of Mechanical Engineering and Materials Science, Institute of Materials Science and Engineering, Washington University in St. Louis, St Louis, Missouri 63130, United States.
Jeremiah J MorrisseyDepartment of Anesthesiology, Division of Clinical and Translational Research, Washington University School of Medicine in St. Louis, St Louis, Missouri 63110, United States.ORCID 0000-0002-9911-4811
Prashant GuptaDepartment of Mechanical Engineering and Materials Science, Institute of Materials Science and Engineering, Washington University in St. Louis, St Louis, Missouri 63130, United States.
Pradeep ChauhanDivision of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St Louis, Missouri 63110, United States.
Russell K PachynskiSiteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, St Louis, Missouri 63110, United States.
Peter K HarrisDivision of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St Louis, Missouri 63110, United States.
Aadel ChaudhuriSiteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, St Louis, Missouri 63110, United States.
Srikanth SingamaneniDepartment of Mechanical Engineering and Materials Science, Institute of Materials Science and Engineering, Washington University in St. Louis, St Louis, Missouri 63130, United States.ORCID 0000-0002-7203-2613

Funding

METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATIONR21CA236652 · NCI · WASHINGTON UNIVERSITY · PI MORRISSEY, JEREMIAH J, SINGAMANENI, SRIKANTH · 2019 to 2021
$705k
NCI NIH HHS R21 CA236652
6 · The paper itself

Abstract

Traditional cold chain systems of collection, transportation, and storage of biofluid specimens for eventual analysis pose a huge financial and environmental burden. These systems are impractical in pre-hospital and resource-limited settings, where refrigeration and electricity are not reliable or even available. Here, we develop an innovative technology using metal-organic frameworks (MOFs), a novel class of organic-inorganic hybrids with high thermal stability, as encapsulates for preserving the integrity of protein biomarkers in biofluids under ambient or non-refrigerated storage conditions. We encapsulate prostate-specific antigen (PSA) in whole patient plasma using hydrophilic zeolitic imidazolate framework-90 (ZIF-90) for preservation at 40 °C for 4 weeks and eventual on-demand reconstitution for antibody-based assays with recovery above 95% compared to storage at -20 °C. Without ZIF-90 encapsulation, only 10-30% of the PSA immunoactivity remained. Furthermore, we demonstrate encapsulation of multiple cancer biomarker proteins in whole patient plasma using ZIF-8 or ZIF-90 encapsulants for eventual on-demand reconstitution and analysis after 1 week at 40 °C. Overall, MOF encapsulation of patient biofluids is important as climate change may be affecting the stability and increase costs of maintaining biospecimen cold chain custody for the collection, transportation, and storage of biospecimens prior to analysis or for biobanking regardless of any countries' affluence.

Indexed as

Metal-Organic FrameworksBiological Specimen BanksHumansMaleProstate-Specific AntigenMetal-Organic FrameworksProstate-Specific Antigenbiopreservationmetal−organic frameworkplasmon-enhanced fluoroimmunoassayplasmonic-fluorprostate-specific antigen

Identifiers

PMID37015072
PMCPMC10484212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.